VIRAL DYNAMICS AND EARLY VIRAL RESPONSE AT WEEK 4 IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGINTERFERON α2B AND RIBAVIRIN

被引：0
|
作者：
Loaeza del Castillo, Aurora [1 ]
Sixtos-Alonso, S. [1 ]
Sanchez-Avila, F. [1 ]
Uribe, M. [1 ]
机构：
[1] Inst Nacl Ciencias Med & Nutr Salvador Zubiran, Mexico City, DF, Mexico
来源：
HEPATOLOGY | 2009年 / 50卷 / 04期
关键词：
D O I：
暂无
中图分类号：
R57 [消化系及腹部疾病];
学科分类号：
摘要：
1436
引用
收藏
页码：965A / 965A
页数：1
相关论文
共 50 条
  • [31] Randomized trial of peginterferon α-2a plus ribavirin versus peginterferon α-2b plus ribavirin for chronic hepatitis C in Japanese patients
    Miyase, Shiho
    Haraoka, Katsuki
    Ouchida, Yoshihiro
    Morishita, Yuko
    Fujiyama, Shigetoshi
    JOURNAL OF GASTROENTEROLOGY, 2012, 47 (09) : 1014 - 1021
  • [32] Hepatitis C virus core Antigen as a predictor of non-response in genotype 1 chronic hepatitis C patients treated with peginterferon α-2b plus ribavirin
    Buti, M
    Mendez, C
    Schaper, M
    Sauleda, S
    Valdes, A
    Rodriguez-Frias, F
    Jardi, R
    Esteban, R
    JOURNAL OF HEPATOLOGY, 2004, 40 (03) : 527 - 532
  • [33] Personalized peginterferon plus ribavirin therapy maximizes viral suppression in patients with chronic hepatitis C
    不详
    Drugs & Therapy Perspectives, 2008, 24 (7) : 18 - 21
  • [34] Viral dynamics and prediction of response to treatment with pegylated interferon and ribavirin in patients with chronic hepatitis C
    Aguilar Reina, J.
    REVISTA ESPANOLA DE ENFERMEDADES DIGESTIVAS, 2009, 101 (10) : 665 - 667
  • [35] Early predictors of sustained viral response (SVR) in chronic hepatitis C (Genotype 4) patients treated with pegylated interferon alpha-2a and ribavirin
    Elmakhzangy, HI
    Rekacewicz, C
    Shouman, S
    Mohamed, HN
    Esmat, G
    Mansour, AA
    Ismail, A
    Rafaat, R
    Elhosseiny, M
    Eldaly, M
    Elkafrawy, S
    Abdel-Hamid, M
    Fontanet, A
    Pol, S
    Mohamed, MK
    GASTROENTEROLOGY, 2005, 128 (04) : A714 - A714
  • [36] Interferon alfa 2b and ribavirin combination therapy for patients with chronic viral hepatitis C failing interferon therapy
    Galica, M
    Alhajjar, B
    Salen, G
    Dyrszka, H
    Sanghavi, B
    Eskreis, D
    HEPATOLOGY, 1998, 28 (04) : 709A - 709A
  • [37] EFFICACY OF A "ON-TREATMENT VIRAL RESPONSE TAILORED REGIMEN" WITH PEGINTERFERON (PEGIFN) ALFA 2B PLUS RIBAVIRIN IN NAiVE GENOTYPE 1 CHRONIC HEPATITIS C (CHC) MEXICAN PATIENTS
    Sanchez-Avila, Juan F.
    Cerda, Eduardo
    Garcia-Leiva, Jorge
    Chavez-Ayala, Alejandro
    Loaeza del Castillo, Aurora
    Sanchez-Osorio, Magdalena
    Meixueiro-Daza, Arturo
    Montano-Loza, Aldo J.
    Uribe-Uribe, Norma
    Vargas-Vorackova, Florencia
    Uribe-Esquivel, Misael
    HEPATOLOGY, 2009, 50 (04) : 703A - 703A
  • [38] Response-guided peginterferon-alpha-2b plus ribavirin therapy for chronic hepatitis C patients with genotype 2 and high viral loads
    Sato, Ken
    Hashizume, Hiroaki
    Yamazaki, Yuichi
    Horiguchi, Norio
    Kakizaki, Satoru
    Takagi, Hitoshi
    Mori, Masatomo
    HEPATOLOGY RESEARCH, 2012, 42 (09) : 854 - 863
  • [39] A comparison of sustained viral response in patients with chronic hepatitis C virus (HCV) treated with peginterferon alfa-2a (Peg2a) versus peginterferon alfa-2b (Peg2b) and ribavirin
    Poordad, F
    Tran, TT
    Ayoub, W
    Patel, Y
    AMERICAN JOURNAL OF GASTROENTEROLOGY, 2005, 100 (09): : S130 - S130
  • [40] THE FIRST WEEK HCV KINETICS PREDICTS VIRAL RESPONSE IN CHRONIC HEPATITIS C PATIENTS TREATED WITH PEGYLATED INTERFERON-α PLUS RIBAVIRIN
    Wang, Chun-Hsiang
    Chang, Kuo-Kwen
    HEPATOLOGY, 2011, 54 : 827A - 827A
12345